Published in Conn Med on December 18, 2012
Bariatric emergencies: current evidence and strategies of management. World J Emerg Surg (2013) 0.81
Recurrent Wernicke's Encephalopathy in a 16-Year-Old Girl with Atypical Clinical and Radiological Features. Case Rep Neurol Med (2014) 0.75
Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib. J Clin Oncol (2008) 2.38
Immunotherapy for melanoma: current status and perspectives. J Immunother (2010) 1.72
Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. Br J Haematol (2011) 1.69
Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia. Dermatol Online J (2011) 1.49
Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches. Expert Opin Biol Ther (2013) 1.44
Malignant melanoma in pigmented skin: does the current interventional model fit a different clinical, histologic, and molecular entity? Dermatol Surg (2013) 1.41
Inflammatory and immune-related conditions associated with Waldenström macroglobulinemia: a single center experience. Leuk Lymphoma (2014) 1.39
Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol (2010) 1.19
Peripheral blood immunophenotypic analysis as a diagnostic tool for large granular lymphocyte leukemia. Leuk Lymphoma (2012) 1.07
A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia. Leuk Lymphoma (2013) 1.06
Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer (2012) 1.05
Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP (2011) 1.03
Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Curr Med Res Opin (2013) 1.03
Tumor vaccines in 2010: need for integration. Cell Immunol (2010) 1.02
Lasers, stem cells, and COPD. J Transl Med (2010) 0.95
Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma? J Clin Oncol (2009) 0.91
Immune alterations in malignant melanoma and current immunotherapy concepts. Expert Opin Biol Ther (2013) 0.91
Details of left ventricular remodeling and the mechanism of paradoxical ventricular septal motion after coronary artery bypass graft surgery. J Invasive Cardiol (2011) 0.89
Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity. South Med J (2010) 0.89
Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST. Dermatol Online J (2008) 0.87
Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin (2012) 0.86
Malignant melanoma in African-Americans. Dermatol Online J (2009) 0.86
Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk (2012) 0.85
An unusual presentation of a carcinoid tumor of the common bile duct. JOP (2013) 0.84
Second primary pancreatic adenocarcinoma three years after successfully treated index esophageal cancer. JOP (2014) 0.84
Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma. Expert Opin Pharmacother (2011) 0.83
Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out. Vasc Health Risk Manag (2011) 0.83
Normal values of regional and global myocardial wall motion in young and elderly individuals using navigator gated tissue phase mapping. Age (Dordr) (2013) 0.83
Hepatoid variant of pancreatic cancer: insights from a case and literature review. JOP (2013) 0.83
Acute gout during treatment with paclitaxel for metastatic melanoma. Rheumatology (Oxford) (2009) 0.82
Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide. Leuk Res (2011) 0.81
Fluorodeoxyglucose-induced allergic reaction: a case report. J Oncol Pharm Pract (2012) 0.81
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med (2011) 0.81
Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations. Surg Obes Relat Dis (2013) 0.80
On the missing link between inflammation and cancer. Dermatol Online J (2011) 0.80
The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth? Dermatol Online J (2009) 0.80
Kidney cancer therapy: new perspectives and avenues. Expert Opin Pharmacother (2006) 0.79
Exogenous endothelial cells as accelerators of hematopoietic reconstitution. J Transl Med (2012) 0.79
High-grade solitary extramedullary plasmacytoma arising in skeletal muscle of a kidney transplant recipient. Leuk Res (2011) 0.79
Cholangiocarcinoma and paraneoplastic hypercalcemia: a lethal combination revisited. South Med J (2010) 0.79
Synchronous tumors: adenosquamous carcinoma of pancreas and GIST of stomach. J Gastrointest Cancer (2011) 0.79
Western variant of brain intravascular lymphoma displaying three distinct evolutive radiologic stages. Conn Med (2014) 0.79
Adult biphasic pulmonary blastoma. Conn Med (2013) 0.79
Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies. Thyroid (2008) 0.78
Immune alterations and immunotherapy prospects in head and neck cancer. Expert Opin Biol Ther (2013) 0.78
Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide. Leuk Res (2010) 0.78
Hepatitis associated aplastic anemia: case report and discussion. Conn Med (2014) 0.77
Immune alterations in untreated and treated myelodysplastic syndrome. Expert Opin Drug Saf (2011) 0.77
HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence? Ann Hematol (2014) 0.77
Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma. Expert Opin Pharmacother (2013) 0.77
What are the latest pharmacotherapy options for small bowel adenocarcinoma? Expert Opin Pharmacother (2014) 0.77
Neuroblastoma with a solitary intraventricular brain metastasis visualized on I-123 MIBG scan. J Neuroimaging (2012) 0.77
Updates on immunotherapy in non-small cell lung cancer. Expert Opin Biol Ther (2014) 0.76
Anaphylactic reactions with intravenous vitamin K: lessons from the bedside. Conn Med (2012) 0.76
Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience. Conn Med (2015) 0.76
Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for Creutzfeldt-Jakob disease. J Transl Med (2010) 0.76
Catastrophic arteriovenous thromboembolism as initial manifestation of pancreatic cancer. JOP (2012) 0.76
Persistent hair growth during treatment with the EGFR inhibitor erlotinib. Dermatol Online J (2009) 0.76
Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: is immunosuppression to blame? J Oncol Pharm Pract (2013) 0.76
Primary respiratory failure due to inclusion body myositis: think outside the box. Conn Med (2013) 0.76
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med (2014) 0.76
Association between HBsAg positivity and pancreatic cancer: a meta-analysis. J Gastrointest Cancer (2014) 0.75
Thrombocytopenia, NAFLD, and metabolic syndrome: is there a link? South Med J (2010) 0.75
Lemierre syndrome caused by group C streptococci and associated with red cell aplasia and immune thrombocytopenia. South Med J (2011) 0.75
IFN-conditioned dendritic cells for the therapy of melanoma: what is missing? J Immunother (2011) 0.75
Autoimmune phenomena in untreated and treated marginal zone lymphoma. Expert Opin Pharmacother (2011) 0.75
Low-dose computed tomography: could it be applied for secondary prevention in patients undergoing resection for lung cancer? J Thorac Oncol (2012) 0.75
Refractory DKA as first presentation of acromegaly and a potential role for continuous venovenous hemofiltration in its successful management. Conn Med (2011) 0.75
Newer developments in the immunotherapy of malignant melanoma. J Oncol Pharm Pract (2013) 0.75
Thrombocytopenia in NAFLD: is thrombopoietin involved? South Med J (2010) 0.75
Respiratory failure due to lung involvement with adult T-cell leukemia/lymphoma: case report and review of literature. Conn Med (2014) 0.75
Large granular lymphocytic (LGL) leukemia in an adult with Down syndrome (47,XX,+21). Leuk Res (2009) 0.75
Operated bronchial carcinoids: clinical outcomes and long-term follow-up of a single institution series of 30 patients. Conn Med (2014) 0.75
Squamous cell lung cancer presenting with pulmonary lymphangitic carcinomatosis. J Ark Med Soc (2010) 0.75
A curious case of a 'burned-out' hypereosinophilic syndrome. Leuk Res (2011) 0.75
Diffuse large B-cell lymphoma with lung involvement in a psoriatic arthritis patient treated with methotrexate. Dermatol Online J (2010) 0.75
Rapidly progressive colonic dysplasia/neoplasia in a series of treated lung cancer patients: Is paclitaxel involved? J Oncol Pharm Pract (2012) 0.75
Fixed Drug Eruption Late in the Course of Capecitabine Therapy. Conn Med (2016) 0.75
Syndrome of inappropriate antidiuretic hormone secretion due to marginal zone lymphoma: responding to rituximab. Clin Lymphoma Myeloma Leuk (2012) 0.75
Hyperviscosity syndrome in a patient with kappa light chain myeloma with cryoglobulin properties and alpha thalassemia. Leuk Res (2010) 0.75
Desmoid tumor mimicking GIST recurrence. J Gastrointest Cancer (2014) 0.75
Monostotic Paget's disease involving the calcaneus encountered incidentally on bone scintigraphy. Foot (Edinb) (2012) 0.75
Rapidly Fatal Dissemination of Merkel Cell Carcinoma in a Patient Treated with Alemtuzumab for Chronic Lymphocytic Leukemia. Conn Med (2016) 0.75
An unusual presentation of Kikuchi-Fujimoto disease. Conn Med (2014) 0.75
Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies. Expert Opin Pharmacother (2013) 0.75
Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma. Expert Opin Pharmacother (2010) 0.75
Paraneoplastic psoriasiform dermatitis preceding the diagnosis of chronic myelogenous leukemia. Leuk Res (2010) 0.75
Retinal Detachment and Symptomatic Hypercalcemia in a Patient with Sarcoidosis: Unusual Presentation of a Granulomatous Disease. Conn Med (2016) 0.75
Refractory metastatic thyroid cancer: is Doxorubicin still a valid treatment option? South Med J (2010) 0.75
Functional 'composite' pheochromocytoma-ganglioneuroma presenting as a pancreatic mass. Pancreatology (2012) 0.75
Prevalence of autoimmune hematologic and non-hematologic conditions in large granular lymphocytic leukemia: exploratory analysis of a series of consecutive patients. Leuk Lymphoma (2013) 0.75
CD5 negative mantle cell lymphoma: a different clinical entity? Conn Med (2014) 0.75